NRSN
NeuroSense Therapeutics Ltd

3,589
Mkt Cap
$22.87M
Volume
116,778.00
52W High
$2.60
52W Low
$0.63
PE Ratio
-1.25
NRSN Fundamentals
Price
$0.731
Prev Close
$0.77
Open
$0.76
50D MA
$0.8885
Beta
0.76
Avg. Volume
175,809.18
EPS (Annual)
-$0.5489
P/B
6.57
Rev/Employee
$0.00
$18.98
Loading...
Loading...

About

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
15

Frequently Asked Questions

What is Market Cap of NeuroSense Therapeutics Ltd?
What is the 52-week high for NeuroSense Therapeutics Ltd?
What is the 52-week low for NeuroSense Therapeutics Ltd?
What is NeuroSense Therapeutics Ltd stock price today?
What was NeuroSense Therapeutics Ltd stock price yesterday?
What is the PE ratio of NeuroSense Therapeutics Ltd?
What is the Price-to-Book ratio of NeuroSense Therapeutics Ltd?
What is the 50-day moving average of NeuroSense Therapeutics Ltd?
How many employees does NeuroSense Therapeutics Ltd have?

Latest NRSN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.